SCHEMBL7608065

SCHEMBL7608065

O=C(NCC(F)(F)C(F)(F)F)OC1(CCCCN2CCN(c3ccc4ccccc4n3)CC2)c2ccccc2-c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.49
DRD3 P35462 7/20 0.47
DRD2 P14416 5/20 0.47
HTR2A P28223 2/20 0.42
HTR3A P46098 3/20 0.41
SLC6A4 P31645 1/20 0.41
HTR2C P28335 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7601003 0.94 HTR1A (0.51) HTR1ADRD3DRD2HTR2AHTR3A
SCHEMBL7596491 0.91 HTR1A (0.48) HTR1ADRD3DRD2HTR2AHTR3A
SCHEMBL6772067 0.87 HTR1A (0.51) HTR1ADRD3DRD2HTR2AHTR3A
SCHEMBL7600485 0.87 HTR1A (0.52) HTR1ADRD3DRD2HTR2AHTR3A
SCHEMBL7598449 0.86 DRD3 (0.50) HTR1ADRD3DRD2HTR2ASLC6A4
SCHEMBL7603379 0.86 HTR1A (0.52) HTR1ADRD3DRD2HTR2AHTR3A
SCHEMBL7596447 0.86 DRD3 (0.54) HTR1ADRD3DRD2HTR2AHTR3A
SCHEMBL7598706 0.86 HTR1A (0.52) HTR1ADRD3DRD2HTR2ASLC6A4
SCHEMBL7596831 0.85 HTR1A (0.42) HTR1ADRD3DRD2HTR2ASLC6A4
SCHEMBL7596536 0.85 DRD3 (0.45) HTR1ADRD3DRD2HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255736-A2 SUBSTITUTED PIPERAZINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) Boehringer Ingelheim Pharma KG (DE) 2002-11-13 EP disclosed
WO-2001047898-A2 SUBSTITUTED PIPERAZINE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-07-05 WO disclosed